Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.

Adverse outcome of critical illness is often caused by systemic inflammation and sepsis. A recent study showed that mortality is significantly reduced by maintenance of normoglycemia using intensive insulin therapy. We examined whether the beneficial effects of intensive insulin therapy involve modulations of mannose-binding lectin (MBL) and C-reactive protein (CRP) levels. From a study of 1548 patients randomly assigned to either conventional treatment or intensive insulin therapy at an intensive care unit (ICU) we included all 451 patients who needed prolonged intensive care (>5 d). CRP and MBL concentrations were measured on admission, d 5, d 15, and the last day in the ICU. In all patients, serum MBL concentrations increased with time in the ICU (P < 0.0001). This acute phase response was suppressed by intensive insulin therapy at all time points studied (P < 0.02). Selectively in patients receiving conventional therapy, MBL concentrations at baseline were almost 3 times higher in survivors than in nonsurvivors (P = 0.04). Baseline CRP concentrations were elevated, but decreased with time in ICU (P < 0.0001). The decrease in CRP was significantly more pronounced in the intensive insulin-treated patients compared with the conventionally treated patients (P </= 0.02) at all time points. Multivariate logistic regression analysis, corrected for all other determinants of outcome, revealed that the antiinflammatory action on CRP, but not on MBL, largely explained the beneficial effects of intensive insulin therapy on morbidity and mortality. In conclusion, intensive insulin therapy exerts a powerful antiinflammatory effect during critical illness which at least partially explains improvement in morbidity and mortality. Possible adverse effects of low baseline MBL are overcome by intensive insulin therapy.

[1]  R. Cooper,et al.  Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. , 2002, American journal of physiology. Endocrinology and metabolism.

[2]  C. Mullighan,et al.  Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. , 2002, Blood.

[3]  W. Lagrand,et al.  Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. , 2002, Journal of clinical pathology.

[4]  S. Thiel,et al.  GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. , 2001, The Journal of clinical endocrinology and metabolism.

[5]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[6]  Michael C. Montalto,et al.  Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury , 2001, Circulation.

[7]  N. Klein,et al.  Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study , 2001, The Lancet.

[8]  S. Thiel,et al.  Association between deficiency of mannose-binding lectin and severe infections after chemotherapy , 2001, The Lancet.

[9]  S. Thiel,et al.  MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. , 2001, Immunity.

[10]  A. Aljada,et al.  Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .

[11]  U. Das.  Is insulin an antiinflammatory molecule? , 2001, Nutrition.

[12]  R. Diaz.  Metabolic modulation of acute myocardial infarction. , 2001, Critical care clinics.

[13]  M. Melbye,et al.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. , 2001, JAMA.

[14]  J. Bradbury.  Oncolytic viral anti-cancer therapy: a magic bullet? , 2001, The Lancet.

[15]  C. Stehouwer,et al.  The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects , 2000, Diabetologia.

[16]  S. Thiel,et al.  Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. , 2000, Journal of immunological methods.

[17]  D. Jack,et al.  Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement Deposition , 2000, Infection and Immunity.

[18]  K. Reinhart,et al.  Treating patients with severe sepsis. , 1999, The New England journal of medicine.

[19]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[20]  L. Piegas,et al.  Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .

[21]  K. Malmberg.  Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[22]  J. Volanakis,et al.  C-reactive protein , 1997, Immunologic research.

[23]  D. Coggon,et al.  Prospective cohort study of predictors of incident low back pain in nurses , 1997, BMJ.

[24]  S. Thiel,et al.  A second serine protease associated with mannan-binding lectin that activates complement , 1997, Nature.

[25]  G. Parmigiani,et al.  The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  A. Imrich,et al.  Immunologic effects of acute hyperglycemia in nondiabetic rats. , 1997, JPEN. Journal of parenteral and enteral nutrition.

[27]  A. Svejgaard,et al.  Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin , 1997, The Lancet.

[28]  A. Svejgaard,et al.  Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency , 1995, The Lancet.

[29]  M. Turner,et al.  Mannose binding protein gene mutations associated with unusual and severe infections in adults , 1995, The Lancet.

[30]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[31]  T. Fujita,et al.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease , 1992, The Journal of experimental medicine.

[32]  S. Thiel,et al.  The concentration of the C‐type lectin, mannan‐binding protein, in human plasma increases during an acute phase response , 1992, Clinical and experimental immunology.

[33]  H. Baumann,et al.  Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. , 1992, Molecular and cellular biology.

[34]  S. Thiel,et al.  ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.

[35]  A. Westman,et al.  Crystalline human chorionic gonadotrophin and its biological action. , 1948 .

[36]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[37]  S. Thiel,et al.  Assays for the functional activity of the mannan-binding lectin pathway of complement activation. , 2002, Immunobiology.

[38]  M. Turner,et al.  Mannose-binding lectin: structure, function, genetics and disease associations. , 2000, Reviews in immunogenetics.

[39]  G. Van den Berghe,et al.  Novel insights into the neuroendocrinology of critical illness. , 2000, European journal of endocrinology.

[40]  G. Van den Berghe,et al.  Increased mortality associated with growth hormone treatment in critically ill adults. , 2000, The New England journal of medicine.

[41]  R. Diaz,et al.  Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. , 1998, Circulation.